Cue Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.About CUE
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in advancing a portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its pipeline includes CUE-221, a novel anti-IgE antibody with a dual mechanism of action, and CUE-401, designed to regulate inflammation and drive Treg-mediated tolerance.
CUE Key Statistics
Stock Snapshot
The current Cue Biopharma(CUE) stock price is $27.67, with a market capitalization of 202.31M. The stock trades at a price-to-earnings (P/E) ratio of -1.00.
On 2026-09-03, Cue Biopharma(CUE) stock traded between a low of $26.60 and a high of $28.00. Shares are currently priced at $27.67, which is +4.0% above the low and -1.2% below the high.
The Cue Biopharma(CUE)'s current trading volume is 65.68K, compared to an average daily volume of 158.21K.
In the last year, Cue Biopharma(CUE) shares hit a 52-week high of $45.50 and a 52-week low of $4.97.
In the last year, Cue Biopharma(CUE) shares hit a 52-week high of $45.50 and a 52-week low of $4.97.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.